StartupHistory

An open directory of startups through time

Public records · dated sources
Free to read. Free to reuse.

Company records / diagonaltx.com

Diagonal Therapeutics

Diagonal Therapeutics (diagonaltx.com): 2 changes recorded in its website history since April 2024. Homepage last checked 5 November 2026.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

  1. InvestorsBetween and

    Now shows investor logos: Headshot of John Lee, Headshot of Patrick Andre, Headshot of Ruhi Ahmed and Jonathan Piazza Headshot.

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  2. HeadlineBetween and
    BeforeADVANCING A GROUND-BREAKING APPROACH TO DISEASE-MODIFYING CLUSTERING ANTIBODY THERAPEUTICS
    AfterAdvancing clustering antibodies to correct the root cause of genetic diseases

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation

First recorded website

Observed 4 April 2024

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

How it described itself

ADVANCING A GROUND-BREAKING APPROACH TO AGONIST ANTIBODY THERAPEUTICS

Diagonal Therapeutics pioneers a new era in medicine by advancing agonist antibody therapeutics targeting the root causes of devastating diseases. Discover our ground-breaking approach to reactivate c

Homepage

Displayed as investors on the website
Dana-Farber · Illumina Ventures · Lilly Asia Ventures · 5am Ventures · Bristol Myers Squibb · OUP · Qatar Investment Authority

archived pageLink to first observation

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

  1. January 2026 – November 2026 · 4 captures · latest observed messagingAdvancing clustering antibodies to correct the root cause of genetic diseases

    Diagonal Therapeutics pioneers a new era in medicine by advancing clustering antibody therapeutics targeting the root causes of devastating diseases.

    This wording observed 5 November 2026.

    current websiteHistorical capture not publicly available
    Inspect 4 captures in this group
    • 8 January 2026 · Advancing clustering antibodies to correct the root cause of genetic diseases archived page
    • 23 January 2026 · Advancing clustering antibodies to correct the root cause of genetic diseases archived page
    • 17 May 2026 · Advancing clustering antibodies to correct the root cause of genetic diseases archived page
    • 5 November 2026 · Advancing clustering antibodies to correct the root cause of genetic diseases current websiteHistorical capture not publicly available
  2. April 2024 – July 2025 · 5 capturesADVANCING A GROUND-BREAKING APPROACH TO DISEASE-MODIFYING CLUSTERING ANTIBODY THERAPEUTICS

    Diagonal Therapeutics pioneers a new era in medicine by advancing agonist antibody therapeutics targeting the root causes of devastating diseases. Discover our ground-breaking approach to reactivate c

    This wording observed 10 July 2025.

    archived page
    Inspect 5 captures in this group
    • 4 April 2024 · ADVANCING A GROUND-BREAKING APPROACH TO AGONIST ANTIBODY THERAPEUTICS archived page
    • 12 September 2024 · ADVANCING A GROUND-BREAKING APPROACH TO AGONIST ANTIBODY THERAPEUTICS archived page
    • 13 January 2025 · ADVANCING A GROUND-BREAKING APPROACH TO AGONIST ANTIBODY THERAPEUTICS archived page
    • 10 July 2025 · ADVANCING A GROUND-BREAKING APPROACH TO DISEASE-MODIFYING CLUSTERING ANTIBODY THERAPEUTICS archived page
    • 10 July 2025 · ADVANCING A GROUND-BREAKING APPROACH TO DISEASE-MODIFYING CLUSTERING ANTIBODY THERAPEUTICS archived page
Summary of the record · AI-written

Written by an AI model on 7 November 2026 from the dated observations above; this is not the date the changes happened; each point links to the changes it rests on.

Diagonal Therapeutics updates homepage messaging and investor section

Diagonal Therapeutics revised its homepage headline about clustering antibodies for genetic diseases and now shows several named investor headshots on its site. These updates may reflect clarified positioning and a choice to highlight identified individual backers.

  • Between July 2025 and January 2026, Diagonal Therapeutics changed its homepage headline to “Advancing clustering antibodies to correct the root cause of genetic diseases”. [1]
  • Between January 2026 and May 2026, the company began showing investor headshots for John Lee, Patrick Andre, Ruhi Ahmed and Jonathan Piazza. [2]
  • Reading: This updated headline suggests an emphasis on clustering antibodies aimed at underlying causes of genetic diseases. [1]
  • Reading: The addition of named investor headshots is consistent with Diagonal Therapeutics choosing to highlight specific individual backers on its site. [2]

Cite this record

StartupHistory, “Diagonal Therapeutics” company record, https://startuphistory.org/c/diagonaltx.com

Machine-readable: /c/diagonaltx.com.json. How changes are found: method.